Form 4 Tracker
Eric Venker

Director, Chief Executive Officer; President & Immunovant CEO · 14 filings · Latest: Oct 1, 2026

Immunovant, Inc.
Roivant Sciences Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ROIV
Venker Eric—Oct 8, 2025
Proposed Sale
$16.20138,602$2.2M—
ROIV
Venker Eric—Oct 7, 2025
Proposed Sale
$16.15355,161$5.7M—
ROIV
Venker Eric—Oct 6, 2025
Proposed Sale
$16.34171,396$2.8M—
ROIV
Venker Eric—Sep 23, 2025
Proposed Sale
$14.94611,079$9.1M—
ROIV
ERIC VENKER—Sep 22, 2025
Proposed Sale
$14.99316,182$4.7M—
ROIV
Venker Eric—Sep 22, 2025
Proposed Sale
$15.01100,000$1.5M—
ROIV
ERIC VENKER—Sep 19, 2025
Proposed Sale
$14.95683,818$10.2M—
ROIV
Venker Eric—Aug 20, 2025
Proposed Sale
$11.72100,000$1.2M—
ROIV
Venker Eric—Jul 21, 2025
Proposed Sale
$11.52100,000$1.2M—
ROIV
Venker Eric—Jun 20, 2025
Proposed Sale
$11.45100,000$1.1M—
ROIV
ERIC VENKER—Jun 3, 2025
Proposed Sale
$11.22566,278$6.4M—
ROIV
ERIC VENKER—Jun 2, 2025
Proposed Sale
$11.07433,722$4.8M—
ROIV
Venker Eric—May 20, 2025
Proposed Sale
$10.95100,000$1.1M—
ROIV
Venker Eric—Apr 21, 2025
Proposed Sale
$10.22100,000$1.0M—
ROIV
Venker Eric—Mar 20, 2025
Proposed Sale
$10.95650,000$7.1M—
ROIV
Venker Eric—Mar 20, 2025
Proposed Sale
$11.11100,000$1.1M—
ROIV
Venker Eric—Feb 20, 2025
Proposed Sale
$10.65100,000$1.1M—
ROIV
Venker Eric—Feb 12, 2025
Proposed Sale
$10.50600,000$6.3M—
ROIV
Venker Eric—Jan 21, 2025
Proposed Sale
$11.28100,000$1.1M—
ROIV
Venker Eric—Dec 27, 2024
Proposed Sale
$11.75360,000$4.2M—